At CES, companies argue that telehealth can actually work

During the COVID-19 pandemic, the fear of patients of being infected in healthcare facilities has driven many of them to use telehealth from the comfort of their homes. This has come with a few benefits. As telehealth has become more mainstream, many providers and patients have appreciated the ease and convenience of home doctor’s appointments, and this has helped patients who have struggled to access health care, either. because they live far from their provider, or because of a state of health which makes mobility difficult.

But remote appointments have made certain types of care and follow-up more difficult. Without touching a patient, for example, checking vital signs is more difficult.
[time-brightcove not-tgx=”true”]

Companies that exhibited their inventions at the 2022 tech convention CES are trying to fill this void. Their innovations offer patients new ways to connect with healthcare providers while bringing together new sources of patient health information. This data has the potential to give healthcare providers a more complete picture of their patient and to deliver more personalized and potentially better care. Here are some of the notable CES 2022 innovations aimed at making telehealth more useful.

Abbott NeuroSphere Virtual Clinic

Abbott NeuroSphere Virtual Clinic The app offers patients a platform where they can conduct video chats with their doctors and access treatments remotely. While a patient is seated in their living room, their clinician can connect to their implanted medical device via WiFi and remotely perform treatments for chronic pain and movement disorders like Parkinson’s disease, including spinal stimulation, dorsal root ganglia therapy, and deep brain stimulation therapy. The patient can also take charge of his therapy and access the stimulation parameters prescribed on his smartphone. The virtual clinic received approval from the U.S. Food and Drug Administration (FDA) in March.

During Abbott’s demonstration of the tool at CES, Dr Fiona Gupta, director of the movement disorders awareness program at Mount Sinai Health System and assistant professor of neurology, said that one of the benefits of the tool is that she can see how her patients are moving in the spaces where they will be the most: their own home. “They can show me how they play the piano, how they interact with their pets, and how they navigate their kitchens,” Gupta said. “It gives me the opportunity to personalize their deep brain stimulation and help them keep doing the things they love to do.”

EarlySense InSight at Home

Many new tools connecting patients to their healthcare providers require patients to interact with a device, but EarlySense InSight at Home only asks them to sleep in their own beds. The sensor, which is placed under a person’s mattress, collects data overnight about breathing patterns, heart rate and body movements, and signals issues such as unstable heart rate or depression respiratory rate. The sensor then uses algorithms and AI modeling to detect changes in a patient’s health and uploads data to the Early Sense cloud, which can be integrated into patient care systems or dashboards. It should be widely available in the second half of 2022.

Jasper Health Digital Oncology Platform

Getting cancer treatment may never be easy, but the Jasper Digital Oncology Platform aims to make it more organized. It allows patients to follow their care regimen, recording appointments, medications and symptoms, and connects them with support, including experts who can answer patient questions. Jasper can also connect patients to clinical care and case management by connecting to biometric monitoring devices.

BioIntelliSense BioSticker and BioButton

Some portable devices are now able not only to record patients’ vital signs, but also to transmit them directly to their doctors. Two of the new tools are the BioSticker and the BioButton, produced by the company BioIntelliSense. Disposable and portable devices can record information such as skin temperature, respiratory rate and body position. The devices were used during the COVID-19 pandemic; for example, when University of Colorado Health first Pfizer-BioNTech vaccine distributed healthcare workers, he used the BioButton to track patients’ vital signs for side effects. The BioSticker is FDA approved.

Leave a Reply

Your email address will not be published. Required fields are marked *